Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1 Study of Ertugliflozin in Healthy Male Participants (MK-8835-020)
- Status
- COMPLETED
- Phase
- PHASE1
Rocuronium + Sugammadex vs. Succinylcholine + Cisatracurium + Neostigmine/Atropine in Obese Participants (MK-8616-104)
- Status
- WITHDRAWN
- Phase
- PHASE4
Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy
- Status
- TERMINATED
- Phase
- PHASE4
Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial
- Status
- COMPLETED
- Phase
- PHASE2
The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion
- Status
- COMPLETED
- Phase
- PHASE4
Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024)
- Status
- COMPLETED
- Phase
- PHASE3
Reversing Therapy Resistance With Epigenetic-Immune Modification
- Status
- TERMINATED
- Phase
- PHASE2
Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation
- Status
- COMPLETED
- Phase
- PHASE4
Evaluation of MK-1075 in Participants With Hepatitis C Virus (HCV) Infection (MK-1075-002)
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117)
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Raltegravir Based Regimen on Platelet Reactivity, Platelet-monocyte Aggregation and Immune Activation
- Status
- COMPLETED
- Phase
- PHASE4
The Implementation of Pharmacogenomics Into Primary Care in British Columbia
- Status
- COMPLETED
- Phase
- NA